By upregulating the HO-1/Nrf2 pathway, the application of low molecular weight blue mussel hydrolysate impedes the differentiation of mouse mesenchymal stem cells into fat cells, thus improving the condition of obesity. Here, NFE2L2 is linked to obesity disorder.